Trivalent FMD Vaccine Supply and Delivery

The North West Department of Agriculture and Rural Development (DARD) has issued Bid 13 DARD 17/2026 for the supply and delivery of trivalent Foot and Mouth Disease (FMD) vaccines. The requirement is for 657,000 doses of FMD oil-based vaccine in 120/100 ml presentations, covering the three Southern African Territories (SAT 1, 2 and 3). The vaccines are required to control and prevent the spread of FMD, a highly contagious viral disease affecting cloven-hoofed livestock, and support the province's veterinary and animal health programmes. Delivery must be made to the Potchefstroom Veterinary Laboratory at 114 Chris Hani Drive, Potchefstroom, with the total price including delivery costs and the cold chain maintained throughout transit. Pricing must be quoted in South African Rand and be VAT inclusive, and bids must remain valid for 90 days from the closing date of 13 November 2026 at 11:00.

Bidders must pass a mandatory pre-qualification stage. This requires a valid Central Supplier Database (CSD) registration report, fully completed and signed Standard Bidding Documents (SBD 1, SBD 4 and SBD 6.1 in original form), a SARS Tax PIN with tax compliance status, and proof of capacity to supply trivalent vaccine for SAT 1, 2 and 3. Suppliers must also provide a SAHPRA Section 21 Authorisation Certificate, proof of a corresponding Veterinary Import Permit, and reference letters demonstrating capacity to supply large volumes of vaccines. Joint ventures must be registered on the CSD with full disclosures. Bids are evaluated in phases: mandatory document compliance, then 80 points for price and 20 points for specific goals under the Preferential Procurement Policy Framework Act and 2022 Regulations, with specific goals covering black-owned, youth-owned, disabled-person-owned, women-owned enterprises and military veterans. Late, emailed or faxed bids are not accepted, and bids must be deposited in the bid box at the Training Centre Building, corner Onkgopotse Tiro Road and Moshoeshoe Drive, Mmabatho. No compulsory briefing session is scheduled. Standard General Conditions of Contract (GCC, July 2010) apply, including penalties for late delivery, performance security, and warranty obligations.

This tender offers a significant opportunity for established veterinary pharmaceutical suppliers and biological product manufacturers with the regulatory approvals, import capacity and cold-chain logistics needed to deliver large volumes of vaccine. Because the contract involves a regulated biological product with strict import and authorisation requirements, it is best suited to licensed manufacturers, accredited distributors or the authorised representatives of international vaccine producers. Bidders should confirm their SAHPRA and import permit status well before the closing date, as these are mandatory and failure to submit them will result in disqualification.